RARE: Ultragenyx Pharmaceutical Inc
RARE exchange rate has changed by 0.19% for today. During the day, the instrument was traded at a low of 15.60 and at a high of 16.25.
Follow Ultragenyx Pharmaceutical Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
RARE News
- Stocks Finish Mostly Higher on Earnings Optimism
- Stocks Rebound on Strong Earnings and Lower Bond Yields
- Stocks Pressured by Tech Stock Weakness and Higher Crude Oil Prices
- Ultragenyx Settles DOJOLVI Patent Litigation With Navinta, Allowing Generic Entry Starting January 1, 2033; Or July 2033 With Pediatric Exclusivity; Similar Patent Litigation Against Other DOJOLVI Abbreviated New Drug Application Filers Related To...
- UBS Initiates Coverage On Ultragenyx Pharmaceutical with Neutral Rating, Announces Price Target of $16
- RARE's Fayuvi Approval Spurs Second PRV Sale Worth $203M in a Week
- Can RARE's Approved Product Portfolio Drive Its Next Growth Phase?
- Stocks Finish Lower Ahead of Wednesday’s CPI Report
- Binance to Lower Leverage and Margin Tiers for Multiple USDT-Margined Perpetual Contracts
- Ultragenyx to Sell Rare Pediatric Disease PRV for $210M to Boost Cash
- Stocks Settle Lower on Higher Bond Yields
- Stocks Fall and Bond Yields Rise on Inflation Worries
- Ultragenyx's Gene Therapy for Sanfilippo Syndrome Wins EMA Validation
- Ultragenyx Gene Therapy For MPS IIIA Clears EMA Validation, Holds PRIME And Orphan Designations, Will Fall Under EU Joint Clinical Assessment
- Evercore ISI Group Maintains In-Line on Ultragenyx Pharmaceutical, Raises Price Target to $18
- Barclays Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $35
- Morgan Stanley Maintains Equal-Weight on Ultragenyx Pharmaceutical, Raises Price Target to $20
- RARE Stock Up 13% on FDA Approval of Sanfilippo Syndrome Gene Therapy
- Ultragenyx Wins First Sanfilippo Approval As Analyst Keeps Ratings Modest
- Canaccord Genuity Maintains Buy on Ultragenyx Pharmaceutical, Raises Price Target to $39
- Ultragenyx (RARE) Surges 12.6%: Is This an Indication of Further Gains?
- Cantor Fitzgerald Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $39
- Ultragenyx Pharmaceutical Inc. (RARE) Discusses FDA Approval of FAYUVI as First Treatment for Sanfilippo Syndrome Type A Transcript
- Ultragenyx Pharmaceutical (RARE) Stock Jumps After Hours: Here's Why It Is Trending
Trading Applications for RARE
Frequently Asked Questions
What is RARE stock price today?
Ultragenyx Pharmaceutical Inc stock is priced at 15.95 today. It trades within 15.60 - 16.25, yesterday's close was 15.92, and trading volume reached 4720. The live price chart of RARE shows these updates.
Does Ultragenyx Pharmaceutical Inc stock pay dividends?
Ultragenyx Pharmaceutical Inc is currently valued at 15.95. Dividend policy depends on the company, while investors also watch -53.18% and USD. View the chart live to track RARE movements.
How to buy RARE stock?
You can buy Ultragenyx Pharmaceutical Inc shares at the current price of 15.95. Orders are usually placed near 15.95 or 16.25, while 4720 and 1.08% show market activity. Follow RARE updates on the live chart today.
How to invest into RARE stock?
Investing in Ultragenyx Pharmaceutical Inc involves considering the yearly range 12.73 - 39.89 and current price 15.95. Many compare 6.12% and -35.94% before placing orders at 15.95 or 16.25. Explore the RARE price chart live with daily changes.
What are Ultragenyx Pharmaceutical Inc stock highest prices?
The highest price of Ultragenyx Pharmaceutical Inc in the past year was 39.89. Within 12.73 - 39.89, the stock fluctuated notably, and comparing with 15.92 helps spot resistance levels. Track Ultragenyx Pharmaceutical Inc performance using the live chart.
What are Ultragenyx Pharmaceutical Inc stock lowest prices?
The lowest price of Ultragenyx Pharmaceutical Inc (RARE) over the year was 12.73. Comparing it with the current 15.95 and 12.73 - 39.89 shows potential long-term entry points. Watch RARE moves on the chart live for more details.
When did RARE stock split?
Ultragenyx Pharmaceutical Inc has gone through stock splits historically. These changes are visible in , 15.92, and -53.18% after corporate actions.
- Previous Close
- 15.92
- Open
- 15.78
- Bid
- 15.95
- Ask
- 16.25
- Low
- 15.60
- High
- 16.25
- Volume
- 4.720 K
- Daily Change
- 0.19%
- Month Change
- 6.12%
- 6 Months Change
- -35.94%
- Year Change
- -53.18%
- Act
- 194 K
- Fcst
- 198 K
- Prev
- 200 K
- Act
- 1.728 M
- Fcst
- 1.723 M
- Prev
- 1.703 M
- Act
- 0.0%
- Fcst
- 0.0%
- Prev
- -0.1%
- Act
- Fcst
- Prev
- 1.955%